Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vistagen Therapeutics (VTGN) Non Operating Income (2025)

Historic Non Operating Income for Vistagen Therapeutics (VTGN) over the last 1 years, with Q3 2025 value amounting to $6000.0.

  • Vistagen Therapeutics' Non Operating Income changed N/A to $6000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $4000.0, marking a year-over-year change of. This contributed to the annual value of $600.0 for FY2021, which is N/A changed from last year.
  • Per Vistagen Therapeutics' latest filing, its Non Operating Income stood at $6000.0 for Q3 2025.
  • Vistagen Therapeutics' 5-year Non Operating Income high stood at $6000.0 for Q3 2025, and its period low was -$2000.0 during Q2 2025.